US Stock MarketDetailed Quotes
XGN Exagen
- 5.960
- +0.230+4.01%
Trading Dec 13 12:17 ET
105.12MMarket Cap-6.34P/E (TTM)
6.150High5.730Low182.58KVolume6.000Open5.730Pre Close1.09MTurnover2.58%Turnover RatioLossP/E (Static)17.64MShares6.21052wk High8.16P/B42.12MFloat Cap1.30052wk Low--Dividend TTM7.07MShs Float29.858Historical High--Div YieldTTM7.33%Amplitude1.300Historical Low5.977Avg Price1Lot Size
About Exagen Company
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Company Profile
SymbolXGN
Company NameExagen
Listing DateSep 19, 2019
Issue Price14.00
Founded2002
CEOMr. John Aballi
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address1261 Liberty Way,Suite C
CityVista
ProvinceCalifornia
CountryUnited States of America
Zip Code92081
Phone1-760-560-1501
Websitehttp://www.exagen.com
Company Executives
- Name
- Position
- Salary
- John Aballi
- Director, President and Chief Executive Officer
- 931.95K
- Jeffrey G. Black
- Chief Financial Officer
- --
- Dr. Tina S. Nova, PhD
- Executive Chairman of the Board
- 132.81K
- Ana Hooker
- Independent Director
- 84.20K
- Paul Kim
- Independent Director
- 52.56K
- Frank Stokes
- Independent Director
- 82.70K
- Bruce C. Robertson, PhD
- Independent Director
- 33.75K
- Dr. Scott D. Kahn,PhD
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
